Emerging anticoagulant drugs

被引：19
作者：
Bates, SM
Weitz, JI
机构：
[1] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2003年 / 23卷 / 09期
关键词：
anticoagulant; antithrombotic; venous thromboembolism; arterial thromboembolism; direct thrombin inhibitor;
D O I：
10.1161/01.ATV.0000084827.77945.66
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.
引用
收藏
页码：1491 / 1500
页数：10
相关论文
共 126 条
[1]   Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study [J].
Abraham, E ;
Reinhart, K ;
Svoboda, P ;
Seibert, A ;
Olthoff, D ;
Dal Nogare, A ;
Postier, R ;
Hempelmann, G ;
Butler, T ;
Martin, E ;
Zwingelstein, C ;
Percell, S ;
Shu, V ;
Leighton, A ;
Creasey, AA .
CRITICAL CARE MEDICINE, 2001, 29 (11) :2081-2089
[2]  
Alderman EL, 1998, J AM COLL CARDIOL, V32, P1
[3]   Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia [J].
Amiral, J ;
Lormeau, JC ;
MarfaingKoka, A ;
Vissac, AM ;
Wolf, M ;
BoyerNeumann, C ;
Tardy, B ;
Herbert, JM ;
Meyer, D .
BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (02) :114-117
[4]   HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL [J].
ANTMAN, EM .
CIRCULATION, 1994, 90 (04) :1624-1630
[5]   Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial [J].
Antman, EM .
CIRCULATION, 1996, 94 (05) :911-921
[6]  
AOKI Y, 1994, THROMB HAEMOSTASIS, V71, P452
[7]   Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa [J].
Arnljots, B ;
Ezban, M ;
Hedner, U .
JOURNAL OF VASCULAR SURGERY, 1997, 25 (02) :341-346
[8]  
Bajaj MS, 1997, THROMB HAEMOSTASIS, V78, P471
[9]  
BAJAJ SP, 1985, J BIOL CHEM, V260, P1574
[10]  
BANNER DW, 1993, ADV EXP MED BIOL, V340, P27
12345678910